115 related articles for article (PubMed ID: 28287050)
21. The effect of Kan Jang extract on the pharmacokinetics and pharmacodynamics of warfarin in rats.
Hovhannisyan AS; Abrahamyan H; Gabrielyan ES; Panossian AG
Phytomedicine; 2006 May; 13(5):318-23. PubMed ID: 16635739
[TBL] [Abstract][Full Text] [Related]
22. The alpha-glucosidase inhibitor voglibose (AO-128) does not change pharmacodynamics or pharmacokinetics of warfarin.
Fuder H; Kleist P; Birkel M; Ehrlich A; Emeklibas S; Maslak W; Stridde E; Wetzelsberger N; Wieckhorst G; Lücker PW
Eur J Clin Pharmacol; 1997; 53(2):153-7. PubMed ID: 9403289
[TBL] [Abstract][Full Text] [Related]
23. Effect of the oral renin inhibitor aliskiren on the pharmacokinetics and pharmacodynamics of a single dose of warfarin in healthy subjects.
Dieterle W; Corynen S; Mann J
Br J Clin Pharmacol; 2004 Oct; 58(4):433-6. PubMed ID: 15373937
[TBL] [Abstract][Full Text] [Related]
24. The effects of Danshen (Salvia miltiorrhiza) on pharmacokinetics and pharmacodynamics of warfarin in rats.
Lo AC; Chan K; Yeung JH; Woo KS
Eur J Drug Metab Pharmacokinet; 1992; 17(4):257-62. PubMed ID: 1301354
[TBL] [Abstract][Full Text] [Related]
25. Effects of safflower injection on the pharmacodynamics and pharmacokinetics of warfarin in rats.
Liu Y; Liu S; Shi Y; Qin M; Sun Z; Liu G
Xenobiotica; 2018 Aug; 48(8):818-823. PubMed ID: 28783419
[TBL] [Abstract][Full Text] [Related]
26. Effect of omeprazole on the anticoagulant activity and the pharmacokinetics of warfarin enantiomers in rats.
Zhou Q; Chan E
Eur J Pharm Sci; 2003 Dec; 20(4-5):439-49. PubMed ID: 14659488
[TBL] [Abstract][Full Text] [Related]
27. Puerarin offsets the anticoagulation effect of warfarin in rats by inducing rCyps, upregulating vitamin K epoxide reductase and inhibiting thrombomodulin.
Ge B; Zhang Z; Lam TT; Zuo Z
Biopharm Drug Dispos; 2017 Jan; 38(1):33-49. PubMed ID: 27925234
[TBL] [Abstract][Full Text] [Related]
28. Study of the effect of miglitol on the pharmacokinetics and pharmacodynamics of warfarin in healthy males.
Schall R; Müller FO; Hundt HK; Duursema L; Groenewoud G; Middle MV
Arzneimittelforschung; 1996 Jan; 46(1):41-6. PubMed ID: 8821516
[TBL] [Abstract][Full Text] [Related]
29. Pharmacokinetic and pharmacodynamic evaluation of warfarin and nefazodone coadministration in healthy subjects.
Salazar DE; Dockens RC; Milbrath RL; Raymond RH; Fulmor IE; Chaikin PC; Uderman HD
J Clin Pharmacol; 1995 Jul; 35(7):730-8. PubMed ID: 7560254
[TBL] [Abstract][Full Text] [Related]
30. Pharmacokinetics and pharmacodynamics of warfarin when coadministered with pentosan polysulfate sodium.
Modi NB; Kell S; Simon M; Vargas R
J Clin Pharmacol; 2005 Aug; 45(8):919-26. PubMed ID: 16027402
[TBL] [Abstract][Full Text] [Related]
31. Pharmacokinetic and pharmacodynamic study of interaction of Rhodiola rosea SHR-5 extract with warfarin and theophylline in rats.
Panossian A; Hovhannisyan A; Abrahamyan H; Gabrielyan E; Wikman G
Phytother Res; 2009 Mar; 23(3):351-7. PubMed ID: 18844284
[TBL] [Abstract][Full Text] [Related]
32. The effect of aleglitazar on the pharmacokinetics and pharmacodynamics of S- and R-warfarin in healthy male subjects.
Sanwald-Ducray P; Jamois C; Banken L
J Cardiovasc Pharmacol; 2014 Feb; 63(2):152-7. PubMed ID: 24157957
[TBL] [Abstract][Full Text] [Related]
33. Influence of laropiprant, a selective prostaglandin D2 receptor 1 antagonist, on the pharmacokinetics and pharmacodynamics of warfarin.
Schwartz JI; Liu F; Stroh M; Gipson A; Johnson-Levonas AO; Lasseter KC; Lai E; Wagner JA
Am J Ther; 2009; 16(3):215-23. PubMed ID: 19454860
[TBL] [Abstract][Full Text] [Related]
34. Safflower yellow for injection enhances anti-coagulation of warfarin in rats: implications in pharmacodynamics and pharmacokinetics.
Liu Y; Sun J; Yang C; Qin M; Xu S; Zhao Y; Liu G
Xenobiotica; 2024 Feb; 54(2):75-82. PubMed ID: 38445636
[TBL] [Abstract][Full Text] [Related]
35. The effect of fimasartan, an angiotensin receptor type 1 blocker, on the pharmacokinetics and pharmacodynamics of warfarin in healthy Korean male volunteers: a one-sequence, two-period crossover clinical trial.
Gu N; Kim BH; Lim KS; Kim SE; Nam WS; Yoon SH; Cho JY; Shin SG; Jang IJ; Yu KS
Clin Ther; 2012 Jul; 34(7):1592-600. PubMed ID: 22727611
[TBL] [Abstract][Full Text] [Related]
36. Effect of rosuvastatin on warfarin pharmacodynamics and pharmacokinetics.
Simonson SG; Martin PD; Mitchell PD; Lasseter K; Gibson G; Schneck DW
J Clin Pharmacol; 2005 Aug; 45(8):927-34. PubMed ID: 16027403
[TBL] [Abstract][Full Text] [Related]
37. Significant effect of capecitabine on the pharmacokinetics and pharmacodynamics of warfarin in patients with cancer.
Camidge R; Reigner B; Cassidy J; Grange S; Abt M; Weidekamm E; Jodrell D
J Clin Oncol; 2005 Jul; 23(21):4719-25. PubMed ID: 16034047
[TBL] [Abstract][Full Text] [Related]
38. The stereoselective effects of bucolome on the pharmacokinetics and pharmacodynamics of racemic warfarin.
Matsumoto K; Ishida S; Ueno K; Hashimoto H; Takada M; Tanaka K; Kamakura S; Miyatake K; Shibakawa M
J Clin Pharmacol; 2001 Apr; 41(4):459-64. PubMed ID: 11304904
[TBL] [Abstract][Full Text] [Related]
39. Pharmacokinetic and pharmacodynamic interactions of aspirin with warfarin in beagle dogs.
Shen C; Huang X; Li J; Zhang P; Li L; Zhang W; Hu T; Pappoe F; Huang J; Tang H
Xenobiotica; 2016; 46(6):530-41. PubMed ID: 26548565
[TBL] [Abstract][Full Text] [Related]
40. Influence of taranabant, a cannabinoid-1 receptor inverse agonist, on pharmacokinetics and pharmacodynamics of warfarin.
Schwartz JI; Dunbar S; Yuan J; Li S; Gipson A; Rosko K; Johnson-Levonas AO; Lasseter KC; Addy C; Stoch AS; Wagner JA
Adv Ther; 2008 Nov; 25(11):1175-90. PubMed ID: 18989636
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
